Wai Chun Bio-Technology to Offset Shareholder's Loan Through Convertible Bond Issue

MT NewswiresApr 15 05:01 ET

WAI CHUN BIOTEC (00660) plans to issue new convertible ​Bonds with a principal of 15 million Hong Kong dollars to settle debts to its ultimate controlling Shareholder Lin Qingqu.

WAI CHUN BIOTEC (00660) announced that on April 14, 2025, the company will engage with existing Bonds Holders.

Zhitong FinanceApr 14 18:14 ET

Express News | Wai Chun Bio Technology Ltd - Agreed to Issue New Convertible Bonds in Principal Amount of HK$15 Mln

ReutersApr 14 18:07 ET

Brokerage morning meeting highlights: In the first quarter, the profitability of the mid-stream chemical sector is bottoming out, while the downstream is gradually recovering.

At today's Brokerage morning meeting, HTSC stated that profits in the midstream of the chemical industry are bottoming out in the first quarter, while the downstream is gradually recovering; Sinolink suggested paying attention to the new agile hand supply chain released by Yushu; China Securities Co., Ltd. believes that with the optimization of deposit costs in 2025, the decline in interest spreads in the Banking industry is expected to narrow.

cls.cnApr 2 20:22 ET

WAI CHUN BIOTEC: Interim Report 2024/25

HKEXMar 31 04:52 ET · Announcements

Wai Chun Bio-Technology to Vote April 30 on Capital Reorganization

MT NewswiresMar 28 04:24 ET